MorphoSys AG
MPSYF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $238 | $278 | $180 | $328 |
| % Growth | -14.4% | 54.9% | -45.2% | – |
| Cost of Goods Sold | $58 | $49 | $32 | $9 |
| Gross Profit | $180 | $230 | $147 | $319 |
| % Margin | 75.5% | 82.5% | 82.1% | 97.2% |
| R&D Expenses | $284 | $298 | $225 | $141 |
| G&A Expenses | $86 | $84 | $78 | $51 |
| SG&A Expenses | $93 | $90 | $200 | $159 |
| Sales & Mktg Exp. | $6 | $6 | $122 | $108 |
| Other Operating Expenses | $1 | $62 | $2 | $0 |
| Operating Expenses | $431 | $450 | $425 | $301 |
| Operating Income | -$252 | $162 | -$278 | $119 |
| % Margin | -106% | 58.3% | -154.6% | 36.4% |
| Other Income/Exp. Net | $62 | $238 | -$314 | $5 |
| Pre-Tax Income | -$191 | $18 | -$591 | $22 |
| Tax Expense | -$1 | $169 | -$77 | -$75 |
| Net Income | -$190 | -$151 | -$515 | $98 |
| % Margin | -79.6% | -54.3% | -286.5% | 29.9% |
| EPS | -5.53 | -4.42 | -15.4 | 3.01 |
| % Growth | -25.1% | 71.3% | -611.6% | – |
| EPS Diluted | -5.53 | -4.42 | -15.4 | 2.97 |
| Weighted Avg Shares Out | 34 | 34 | 33 | 33 |
| Weighted Avg Shares Out Dil | 34 | 34 | 33 | 33 |
| Supplemental Information | – | – | – | – |
| Interest Income | $18 | $5 | $97 | $92 |
| Interest Expense | $110 | $117 | $182 | $96 |
| Depreciation & Amortization | $14 | $10 | $10 | $8 |
| EBITDA | -$98 | $173 | -$331 | $128 |
| % Margin | -41% | 62.1% | -184.4% | 39% |